Congress Presentations
Stay informed about the latest scientific and medical research from Axsome.
AMCP Nexus
San Diego, CA | October 26 - 29, 2026
Auvelity® | Major Depressive Disorder
Real-World Clinical Outcomes of Patients Switching to Treatment With Auvelity® (Dextromethorphan-Bupropion)
Auvelity® | Major Depressive Disorder
Impact of Formulary-Related Rejections of Initial Auvelity® (Dextromethorphan-Bupropion [45 mg/105 mg]) Claims on Healthcare Resource Utilization and Costs Among Patients With Major Depressive Disorder
Symbravo® | Migraine
Cost-Effectiveness of Symbravo® (MoSEICTM Meloxicam and Rizatriptan) Compared With Gepants for the Acute Treatment of Migraine in Adults in the United States
Symbravo® | Migraine
Dr. Ailani presents the "Cost Effectiveness of Symbravo® (MoSEICTM Meloxicam and Rizatriptan) Compared with Gepants for the Acute Treatment of Migraine in Adults in the United States" poster
Symbravo® | Migraine
Symbravo® (MoSEICTM Meloxicam and Rizatriptan) for the Acute Treatment of Migraine: Post-Hoc Composite Efficacy and Safety Endpoint Analysis of INTERCEPT and MOMENTU
Symbravo® | Migraine
Dr. Cohen presents the "Symbravo® (MoSEICTM Meloxicam and Rizatriptan) for the Acute Treatment of Migraine: Post-Hoc Composite Efficacy and Safety Endpoint Analysis of INTERCEPT and MOMENTUM" poster
AXS-12 | Narcolepsy
AXS-12 for the Treatment of Narcolepsy: Topline Results From the Phase 3 SYMPHONY Trial
AXS-12 | Narcolepsy
Real-World Healthcare Resource Utilization and Economic Burden of Narcolepsy Type 1 in the US
